1. Home
  2. APLT vs CARS Comparison

APLT vs CARS Comparison

Compare APLT & CARS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • APLT
  • CARS
  • Stock Information
  • Founded
  • APLT 2016
  • CARS 1998
  • Country
  • APLT United States
  • CARS United States
  • Employees
  • APLT N/A
  • CARS N/A
  • Industry
  • APLT Biotechnology: Pharmaceutical Preparations
  • CARS Motor Vehicles
  • Sector
  • APLT Health Care
  • CARS Consumer Discretionary
  • Exchange
  • APLT Nasdaq
  • CARS Nasdaq
  • Market Cap
  • APLT 63.6M
  • CARS 815.4M
  • IPO Year
  • APLT 2019
  • CARS 2017
  • Fundamental
  • Price
  • APLT $0.41
  • CARS $13.33
  • Analyst Decision
  • APLT Buy
  • CARS Strong Buy
  • Analyst Count
  • APLT 6
  • CARS 5
  • Target Price
  • APLT $6.10
  • CARS $17.30
  • AVG Volume (30 Days)
  • APLT 771.9K
  • CARS 638.9K
  • Earning Date
  • APLT 11-06-2025
  • CARS 11-06-2025
  • Dividend Yield
  • APLT N/A
  • CARS N/A
  • EPS Growth
  • APLT N/A
  • CARS 69.36
  • EPS
  • APLT N/A
  • CARS 0.63
  • Revenue
  • APLT $121,000.00
  • CARS $717,845,000.00
  • Revenue This Year
  • APLT N/A
  • CARS $2.52
  • Revenue Next Year
  • APLT $5,931.24
  • CARS $2.93
  • P/E Ratio
  • APLT N/A
  • CARS $21.34
  • Revenue Growth
  • APLT N/A
  • CARS 0.68
  • 52 Week Low
  • APLT $0.30
  • CARS $9.56
  • 52 Week High
  • APLT $10.62
  • CARS $20.47
  • Technical
  • Relative Strength Index (RSI)
  • APLT 38.50
  • CARS 53.22
  • Support Level
  • APLT $0.40
  • CARS $13.15
  • Resistance Level
  • APLT $0.46
  • CARS $13.84
  • Average True Range (ATR)
  • APLT 0.03
  • CARS 0.44
  • MACD
  • APLT -0.01
  • CARS -0.00
  • Stochastic Oscillator
  • APLT 7.74
  • CARS 52.42

About APLT Applied Therapeutics Inc.

Applied Therapeutics Inc is a clinical-stage biopharmaceutical company, developing a pipeline of novel product candidates against validated molecular targets in indications of high unmet medical need. The company's drug compounds pipeline includes AT-007 which is a novel central nervous system, penetrant ARI that it is developing for the treatment of rare metabolic diseases, including Galactosemia and Sorbitol Dehydrogenase (SORD) Deficiency, AT-001 for the treatment of diabetic cardiomyopathy, and AT-003 for the treatment of diabetic retinopathy.

About CARS Cars.com Inc.

Cars.com Inc is an online destination for buying and selling new and used vehicles. It is an audience-driven technology company empowering the automotive industry. The company brands include Dealer Inspire, DealerRater, FUEL, Accu-Trade, PickupTrucks.com, CreditIQ, and NewCars.com., websites directed towards different consumer segments.

Share on Social Networks: